{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:23:32Z","timestamp":1767626612670},"reference-count":48,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold>Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in the preoperative assessment of cardiovascular risk in comparison with clinically accepted cardiac biomarkers and one of the relevant clinical risk scores.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>We included 79 patients, female (41) and male (38), with the mean age of 71.35\u00b16.89. Inclusion criteria: extensive non-cardiac surgery, general anesthesia, age &gt;55 and at least one of the selected cardiovascular risk factors (hypertension, diabetes mellitus, hyperlipidemia, smoking and positive family history). Exclusion criteria: emergency surgical procedures and inability to understand and sign an informed consent. Blood sampling was performed 7 days prior surgery and levels of survivin (BIRC5), hsCRP and H-FABP were measured.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Revised Lee score was assessed based on data found in patients\u2019 history. Levels of survivin (BIRC5) were higher in deceased patients (P&lt;0.05). It showed AUC=0.807 (95% CI, P&lt;0.0005, 0.698\u20130.917), greater than both H-FABP and revised Lee index, and it increases the mortality prediction when used together with both biomarkers and revised Lee score. The determined cut-off value was 4 pg\/mL and 92.86% of deceased patients had an increased level of survivin (BIRC5), (P=0.005).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>Survivin (BIRC5) is a potential cardiac biomarker even in elderly patients without tumor, but it cannot be used independently. Further studies with a greater number of patients are needed.<\/jats:p>","DOI":"10.1515\/jomb-2017-0046","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T10:01:24Z","timestamp":1506333684000},"page":"110-120","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-Sensitivity C-Reactive Protein, Heart-Type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-Cardiac Surgery: A Prospective Pilot Study"],"prefix":"10.5937","volume":"37","author":[{"given":"Danica","family":"Markovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Jevtovi\u0107-Stoimenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladan","family":"\u0106osi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Sto\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Dini\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Markovi\u0107-\u017divkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radmilo J.","family":"Jankovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref221","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/TP.0b013e31829e2703","article-title":"Revised Cardiac Risk Index is a useful tool for evaluation of perioperative cardiac morbidity in kidney transplant recipients","volume":"23","author":"Hoftman","year":"2013","journal-title":"Transplantation"},{"key":"ref141","first-page":"1999","article-title":"incidence mortality in","volume":"15","author":"Mihajlovi\u0107","year":"2009","journal-title":"Cancer BMC Cancer"},{"key":"ref281","first-page":"2015","article-title":"- type fatty acid binding protein in patients in an emergency department setting suspected of acute coronary syndrome : optimal cut - off point diagnostic value and future opportunities in primary care","volume":"29","author":"Willemsen","journal-title":"Heart Eur Gen"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1177\/2048872616684678)","article-title":"Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT NT - proBNP and hsCRP with the GRACE score Acute Cardiovasc Care","author":"Klingenberg","year":"2016","journal-title":"Eur Heart J"},{"key":"ref181","first-page":"203","article-title":"Surgical risk factors morbidity and mortality in elderly patients","volume":"19","author":"Turrentine","year":"2006","journal-title":"Am"},{"key":"ref51","first-page":"217","article-title":"and Evaluation of the Universal ACS NSQIP Surgical Risk Calculator Decision Aid and Informed Consent Tool for Patients and Surgeons","author":"Bilimoria","year":"2013","journal-title":"Development Am"},{"key":"ref391","first-page":"2015","article-title":"Cardioprotective actions of TGF RI inhibition through stimulating autocrine \/ paracrine of survivin and inhibiting Wnt in cardiac progenitors","volume":"34","author":"Ho","journal-title":"Cell"},{"key":"ref81","first-page":"392","article-title":"Clinical indices and biomarkers for perioperative cardiac risk stratification : an update","author":"Jankovi\u0107","year":"2017","journal-title":"Minerva Anestesiol"},{"key":"ref271","first-page":"1","article-title":"- Type Fatty Acid Binding Protein and Ischemia - Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft","volume":"28","author":"Thielmann","year":"2017","journal-title":"Heart Surgery Ann Thorac Surg"},{"key":"ref41","article-title":"AHA Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery : Executive Summary Report of the American College of Heart Association Task Force on Practice Guidelines ( Writing Committee to Revise the Guidelines on Peri","author":"Fleisher","year":"2007","journal-title":"Cardiology American Surgery Society Echocardiography American Society Cardiology Heart Rhythm Society Society Society Society Vascular Medicine Society Vascular Surgery J Am Coll Cardiol"},{"key":"ref121","first-page":"2015","article-title":"significance of pretreatment survivin serum levels in patients with serous ovarian carcinoma","volume":"13","author":"Dobrzycka","journal-title":"Tumour Biol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-5-153","article-title":"The impact of age on post - operative outcomes of colorectal cancer patients undergoing surgical treatment","volume":"18","author":"Latkauskas","year":"2005","journal-title":"BMC Cancer"},{"key":"ref191","first-page":"90","article-title":"Age as an independent risk factor for postoperative morbidity and mortality after total joint arthroplasty in patients years of age or older","volume":"20","author":"Apuzzo","year":"2014","journal-title":"J Arthroplasty"},{"key":"ref471","first-page":"19","article-title":"High expression of survivin mRNA in colorectal carcinoma","volume":"23","author":"Stanilov","year":"2009","journal-title":"IL Int J Colorectal Dis"},{"key":"ref131","first-page":"185","article-title":"cardiovascular evaluation for non cardiac","volume":"14","author":"Maddox","year":"2005","journal-title":"surgery Mt Sinai J Med"},{"key":"ref401","first-page":"400","article-title":"Protective effect of survivin in doxorubicin - induced cell death in cardiac myocytes","volume":"9","author":"Lee","year":"2013","journal-title":"Circ J"},{"key":"ref201","first-page":"2015","article-title":"Perioperative factors predicting poor outcome in elderly patients following emergency general surgery : a multivariate regression analysis","volume":"21","author":"Lees","journal-title":"Can J Surg"},{"key":"ref461","first-page":"11","article-title":"Expression and significance of survivin in colon cancer","volume":"23","author":"Jiang","year":"2004","journal-title":"Ai"},{"key":"ref261","first-page":"120","article-title":"- type fatty acid - binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients Cardiac Fail","volume":"27","author":"Niizeki","year":"2007","journal-title":"Heart"},{"key":"ref01","first-page":"1","article-title":"The Joint Task Force on non - cardiac cardiovascular assessment and management of the European Society of and the European Society of ESA ESA Guidelines on non - cardiac cardiovascular assessment and management","year":"2014","journal-title":"surgery Cardiology Anaesthesiology surgery Eur Heart J"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.avsg.2014.01.012","article-title":"Combined use of high - sensitivity reactive protein and terminal pro - type natriuretic peptide for risk stratification of vascular surgery patients","volume":"28","author":"Scrutinio","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"ref331","first-page":"71","article-title":"High - sensitivity reactive protein and terminal pro - type natriuretic peptide in patients with stable coronary artery disease : a prognostic study within the CLARICOR Trial","author":"Harutyunyan","year":"2011","journal-title":"Clin Lab Invest"},{"key":"ref381","first-page":"39","article-title":"Surviving acute myocardial infarction : survivin expression in viable cardiomyocytes after infarction","author":"Santini","year":"2004","journal-title":"J Clin Pathol"},{"key":"ref211","first-page":"53","article-title":"Outcomes in heart failure patients after major noncardiac surgery","volume":"22","author":"Hernandez","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref151","first-page":"2015","article-title":"Quality of life of the elderly in urban and rural areas in Serbia Kvalitet ivota starih u urbanoj i ruralnoj sredini u","volume":"16","author":"Uro\u0161evi\u0107","journal-title":"Vojnosanit Pregl"},{"key":"ref111","first-page":"9","article-title":"Role of the zebrafish survivin genes in vasculo - angiogenesis neurogenesis cardiogenesis","volume":"12","author":"Delvaeye","year":"2009","journal-title":"hematopoiesis BMC Dev Biol"},{"key":"ref531","article-title":"CD Clinical significance of survivin expression in patients with urothelial carcinoma","author":"Chen HA","year":"2014","journal-title":"Dis Markers"},{"key":"ref231","first-page":"519","article-title":"The Revised Cardiac Risk Index in the new millennium : a single - centre prospective cohort re - evaluation of the original variables in consecutive elective surgical patients Can","volume":"24","author":"Davis","year":"2013"},{"key":"ref451","first-page":"2015","article-title":"Serum survivin levels and outcome fo chemotherapy in patients with malignant mesothelioma Article ID","author":"Gori\u010dar","journal-title":"Dis Markers"},{"key":"ref491","article-title":"Increased expression of inhibitor of apoptosis proteins surviving in non - small cell lung carcinoma of","author":"Krepela","year":"2009","journal-title":"International Journal Oncology"},{"key":"ref291","first-page":"2015","article-title":"Diabetic patients have increased perioperative cardiac risk in heart - type fatty acid - binding protein - based assessment","volume":"30","author":"Sari","journal-title":"Med"},{"key":"ref501","first-page":"2015","article-title":"Serum surviving increases in prolactinoma","volume":"51","author":"Dellala","journal-title":"Clin Med Res"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1476-4598-13-209","article-title":"Survivin expression promotes VEGF - induced tumor angiogenesis via PI Akt enhanced \u03b2 - catenin Tcf - Lef dependent transcription","volume":"13","author":"Fern\u00e1ndez","year":"2014","journal-title":"Mol Cancer"},{"key":"ref411","first-page":"101","article-title":"Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis","author":"Lee","year":"2014","journal-title":"Cardiovasc Res"},{"key":"ref161","first-page":"7621","article-title":"AB TA Predictors of morbidity and mortality after hepatectomy in elderly patients : analysis of patients","volume":"17","author":"Tzeng","year":"2014"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3343\/alm.2016.36.5.420","article-title":"Kin The prognostic value of serum levels of heart - type fatty acid binding protein and high sensitivity C - reactive protein in patients with increased levels of amino - terminal pro - type natriuretic peptide","volume":"36","author":"Jeong","year":"2016","journal-title":"Ann Lab Med"},{"key":"ref101","first-page":"101","article-title":"Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis","volume":"11","author":"Lee","year":"2014","journal-title":"Cardiovasc Res"},{"key":"ref251","first-page":"112","article-title":"new revised cardiac risk index incorporating fragmented QRS complex as a prognostic marker in patients undergoing noncardiac vascular surgery","volume":"26","author":"Jang","year":"2013","journal-title":"Am J Cardiol"},{"key":"ref301","first-page":"2015","article-title":"Comparative study of high sensitivity troponin heart - type fatty acid - binding protein in STEMI patients Saudi","volume":"31","author":"Banu","journal-title":"Biol Sci"},{"key":"ref481","first-page":"49","article-title":"Comparison of serum survivin and alpha fetoprotein in Egyptian patients with hepatocellular carcinoma associated with hepatitis C viral infection Asian","volume":"11","author":"Attar","year":"2010","journal-title":"Cancer"},{"key":"ref341","first-page":"2784","article-title":"Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury Transplant","author":"Ozisik","year":"2006","journal-title":"Proc"},{"key":"ref361","first-page":"37","article-title":"ACH The role of survivin in angiogenesis during zebrafish embryonic development","author":"Ma","year":"2007","journal-title":"BMC Dev Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7326\/0003-4819-98-4-504","article-title":"Cardiac risk and complications of noncardiac surgery","volume":"13","author":"Goldman","year":"1983","journal-title":"Ann Intern Med"},{"key":"ref21","first-page":"1","article-title":"AS Predicting cardiac complications in patients undergoing non - cardiac surgery","author":"Detsky","year":"1986","journal-title":"J Gen Intern Med"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12885-016-2304-3","article-title":"You Survivin protein expression is involved in the progression of non - small cell lung cancer in a meta - analysis","volume":"16","author":"Duan","year":"2016","journal-title":"BMC Cancer"},{"key":"ref421","first-page":"013510","article-title":"External validation of the Revised Cardiac Risk Index and update of its renal variable to predict day risk of major cardiac complications after non - cardiac surgery rationale and plan for analyses of the VISION study Open","volume":"30","author":"Roshanov","year":"2017","journal-title":"PS AM"},{"key":"ref511","first-page":"2015","article-title":"expression and serum levels in pancreatic cancer","volume":"13","author":"Dong","journal-title":"World J Surg Oncol"},{"key":"ref441","first-page":"281","article-title":"Molecular analysis of survivin isoforms : Evidence that alternatively spliced variants do not play a role in mitosis","author":"Noton","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Journal of Medical Biochemistry"],"original-title":[],"link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/jomb\/37\/2\/article-p110.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2018\/1452-82581802110M.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T20:34:50Z","timestamp":1588883690000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/article.aspx?artid=1452-82581802110M"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":48,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1515\/jomb-2017-0046","relation":{},"ISSN":["1452-8266"],"issn-type":[{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}